[
  {
    "note_text": "\u2551 \u2551 11R \u2502 13 x 9 \u2502 Normal \u2502 YES \u2502 Benign \u2551 \u255a\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u255d\nDETAILED SAMPLING:\n\u250c\u2500 STATION 7 (SUBCARINAL) \u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510 \u2502 Ultrasound Characteristics: \u2502 \u2502 \u2022 Size: 35mm x 23mm \u2502 \u2502 \u2022 Shape: Round \u2502 \u2502 \u2022 Borders: Well-defined \u2502 \u2502 \u2022 Echotexture: Hypoechoic \u2502 \u2502 \u2022 Hilum: Absent \u2502 \u2502 \u2022 Vascularity: Peripheral pattern \u2502 \u2502 \u2022 Elastography: Score 4/5 (firm) \u2502 \u2502 \u2502 \u2502 Needle Aspiration: \u2502 \u2502 Pass 1 (0915): Excellent sample \u2502 \u2502 \u2514\u2500 ROSE: Adequate, MALIGNANT CELLS \u2502 \u2502 Pass 2 (0918): Confirmatory \u2502 \u2502 \u2514\u2500 ROSE: Adenocarcinoma confirmed \u2502 \u2502 Pass 3 (0921): Molecular testing \u2502 \u2502 Pass 4 (0924): Cell block \u2502 \u2502 \u2502 \u2502 Technique: 20-25 agitations per pass \u2502 \u2502 Complications: None \u2502 \u2514\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2518\n\u250c\u2500 STATION 4R (RIGHT LOWER PARATRACHEAL) \u2500\u2510 \u2502 Ultrasound Characteristics: \u2502 \u2502 \u2022 Size: 27mm x 16mm \u2502 \u2502 \u2022 Shape: Oval \u2502 \u2502 \u2022 Echotexture: Heterogeneous \u2502 \u2502 \u2022 Hilum: Absent \u2502 \u2502 \u2502 \u2502 Needle Aspiration: \u2502 \u2502 Pass 1-3 (0928-0934): \u2502 \u2502 \u2514\u2500 ROSE: MALIGNANT, consistent with \u2502 \u2502 known adenocarcinoma \u2502 \u2514\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2518\n\u250c\u2500 STATION 10R (RIGHT HILAR) \u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510 \u2502 Ultrasound Characteristics: \u2502 \u2502 \u2022 Size: 16mm x 11mm \u2502 \u2502 \u2022 Echotexture: Hypoechoic \u2502 \u2502 \u2502 \u2502 Needle Aspiration: \u2502 \u2502 Pass 1-2 (0937-0940): \u2502 \u2502 \u2514\u2500 ROSE: MALIGNANT CELLS PRESENT \u2502 \u2514\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2518\n\u250c\u2500 STATION 11R (RIGHT INTERLOBAR) \u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510 \u2502 Ultrasound Characteristics: \u2502 \u2502 \u2022 Size: 13mm x 9mm \u2502 \u2502 \u2022 Appearance: Normal hilum preserved \u2502 \u2502 \u2502 \u2502 Needle Aspiration: \u2502 \u2502 Pass 1-2 (0943-0945): \u2502 \u2502 \u2514\u2500 ROSE: BENIGN lymphoid tissue \u2502 \u2514\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2518\nFinal inspection of airways showed no bleeding. Bronchoscope withdrawn. Patient awakened from sedation without difficulty.\n\u2554\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2557 \u2551 RAPID ON-SITE EVALUATION (ROSE) \u2551 \u255a\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u255d\nCytotechnologist: Kevin Morrison, CT(ASCP)\nSTATION 7: POSITIVE FOR MALIGNANCY\n\u2022\tAdenocarcinoma\n\u2022\tCellular atypia consistent with primary lung origin\n\u2022\tTumor cells present in high numbers\nSTATION 4R: POSITIVE FOR MALIGNANCY\n\u2022\tAdenocarcinoma\n\u2022\tMorphology consistent with Station 7\nSTATION 10R: POSITIVE FOR MALIGNANCY\n\u2022\tMalignant cells identified\n\u2022\tConsistent with metastatic adenocarcinoma\nSTATION 11R: NEGATIVE FOR MALIGNANCY\n\u2022\tBenign reactive lymphocytes\n\u2022\tNo atypical cells identified\n\u2554\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2557 \u2551 SPECIMENS SUBMITTED \u2551 \u255a\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u255d\nCYTOLOGY: \u25a1 Station 7 (4 passes) - Cytology, Cell block \u25a1 Station 4R (3 passes) - Cytology \u25a1 Station 10R (2 passes) - Cytology\n\u25a1 Station 11R (2 passes) - Cytology\nANCILLARY TESTING (Station 7): \u25a1 EGFR mutation analysis \u25a1 ALK rearrangement (FISH) \u25a1 ROS1 rearrangement \u25a1 PD-L1 immunohistochemistry \u25a1 Next-generation sequencing panel\nMICROBIOLOGY (Station 7): \u25a1 Bacterial culture \u25a1 Mycobacterial culture (AFB) \u25a1 Fungal culture\n\u2554\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2557 \u2551 PROCEDURE METRICS \u2551 \u255a\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u255d\nProcedure start: 0900 Procedure end: 0948 Total procedure time: 48 minutes Lymph nodes surveyed: 7 stations Lymph nodes sampled: 4 stations\nTotal needle passes: 11 Fluoroscopy: Not used Estimated blood loss: <5mL\n\u2554\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2557 \u2551 COMPLICATIONS \u2551 \u255a\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u255d\nNone. No hypoxemia, no bleeding, no pneumothorax, no hemodynamic instability.\n\u2554\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2557 \u2551 PATIENT TOLERANCE \u2551 \u255a\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u255d\nExcellent. Patient remained hemodynamically stable throughout. SpO2 maintained >95% on supplemental O2 via nasal cannula at 2L/min. No arrhythmias noted. Recovered from sedation appropriately within 30 minutes.\n\u2554\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2557 \u2551 DIAGNOSTIC IMPRESSION \u2551 \u255a\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u255d\n2.\tSUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION\n3.\tN3 DISEASE CONFIRMED - Metastatic adenocarcinoma involving: \u2022 Station 7 (subcarinal) - N2 \u2022 Station 4R (paratracheal) - N2\n\u2022 Station 10R (hilar) - N1 \u2022 Contralateral/bilateral nodal involvement = N3\n4.\tSTAGE IIIC DISEASE (cT2aN3M0) based on ROSE findings\n5.\tStation 11R negative (benign)\n6.\tFinal pathology and molecular testing pending (expected 5-7 business days)\n\u2554\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2557 \u2551 TREATMENT PLAN & RECOMMENDATIONS \u2551 \u255a\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u255d\n2.\tIMMEDIATE: \u25a1 Medical oncology consultation (already scheduled for 03/25/2025) \u25a1 Patient counseled regarding N3 disease and treatment implications \u25a1 Discussed that this finding changes management from surgical candidate to systemic therapy +/- radiation\n3.\tPENDING: \u25a1 Final pathology with molecular markers (EGFR, ALK, ROS1, PD-L1, NGS) \u25a1 Treatment decisions pending molecular results\n4.\tSTAGING COMPLETION: \u25a1 Brain MRI (ordered - to evaluate for metastases) \u25a1 Consider PET-CT if not recent\n5.\tMULTIDISCIPLINARY APPROACH: \u25a1 Tumor board presentation scheduled for 03/27/2025 \u25a1 Thoracic oncology \u25a1 Radiation oncology\n\u25a1 Pulmonology\n6.\tFOLLOW-UP: \u25a1 Interventional Pulmonology clinic in 1 week for pathology review \u25a1 Coordinate care with oncology team \u25a1 Provide support resources and patient education materials\n7.\tPROGNOSIS DISCUSSION: \u25a1 Stage IIIC disease discussed with patient and family \u25a1 Treatment options including chemotherapy, immunotherapy, targeted therapy (if applicable), and radiation reviewed \u25a1 Palliative care consultation offered\n\u2554\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2557 \u2551 ATTESTATION \u2551 \u255a\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u255d\nI personally performed this procedure and was present throughout all critical portions. The patient was appropriately monitored and the procedure was conducted in accordance with standard of care guidelines. All findings and recommendations documented above reflect my professional assessment.\n\u2554\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2557 \u2551 ELECTRONIC SIGNATURE \u2551 \u255a\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u255d\nLawrence Turner, MD, FCCP Board Certified: Pulmonary, Critical Care, Interventional Pulmonology NPI: 1234567890\nDate: 03/23/2025 Time: 10:15 AM\n\u2554\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2557 \u2551 DISTRIBUTION \u2551 \u255a\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u255d \u25a1 Electronic Medical Record \u25a1 Referring Physician: Dr. Sarah Martinez (Primary Care) \u25a1 Medical Oncology: Dr. Robert Kim \u25a1 Patient Portal (results letter to follow)\n\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\n________________________________________",
    "cpt_codes": [
      31653
    ],
    "registry_entry": {
      "procedure_date": "2025-03-23",
      "providers": {
        "attending_name": "Lawrence Turner"
      },
      "metadata": {
        "generated_at": "2025-12-01T15:40:50.162714"
      },
      "cpt_codes": [
        31653
      ],
      "ebus_stations_sampled": [
        "10R",
        "11R",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10R",
        "11R",
        "4R",
        "7"
      ],
      "coding_review": {
        "reviewer": "IP-Coder-Patch-GPT",
        "review_date": "2025-12-06",
        "cpt_summary": [
          {
            "code": "31653",
            "description": "Bronchoscopy; with EBUS sampling, 3 or more nodal stations",
            "units": 1,
            "modifiers": [],
            "primary": true,
            "facility_rvu_2025": 7.7,
            "facility_payment_2025": 249,
            "rationale": "EBUS-TBNA performed on 4 stations (4R, 7, 10R, 11R) with ROSE."
          }
        ],
        "rvus_and_payments_2025": {
          "facility_total_rvu": 7.7,
          "facility_total_payment": 249
        }
      }
    },
    "source_file": "synthetic_notes_with_CPT.csv",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.2.0",
      "patch_date": "2025-12-07T00:00:00",
      "changes": [
        "Extracted CPT codes: [31629, 31622, 31653]",
        "Extracted EBUS stations: ['10R', '11R', '4R', '7']",
        "Extracted attending: Sarah Martinez",
        "Coder review: updated attending to Lawrence Turner, removed 31629 and 31622 so EBUS staging is billed with 31653 only, and added registry_entry.coding_review with 2025 facility RVUs and payments."
      ],
      "warnings": []
    }
  },
  {
    "note_text": "\u2551 \u2551 11L \u2502 19x13mm \u2502 Hypoechoic \u2502 YES \u2502 MALIGNANT\u2551 \u255a\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u255d\nTRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED:\n\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501 STATION 7 - SUBCARINAL NODE \u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\nUltrasound Characteristics:\n\u2022\tLocation: Between RMB and LMB, posterior position\n\u2022\tDimensions: 41mm (long) x 27mm (short) x 24mm (depth)\n\u2022\tShape: Round\n\u2022\tBorders: Well-defined\n\u2022\tEchotexture: Diffusely hypoechoic\n\u2022\tHilum: Completely absent\n\u2022\tNecrosis: None evident\n\u2022\tVascularity: Peripheral vessels on color Doppler\n\u2022\tElastography: Score 5/5 - very firm (blue pattern)\nINTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY\nAspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass).\nPass 1 (0842):\n\u2022\tExcellent sample obtained\n\u2022\tVisible tissue core in needle hub\n\u2022\tROSE: ADEQUATE specimen, abundant cellularity\n\u2022\tROSE: MALIGNANT CELLS IDENTIFIED\n\u2022\tROSE: Morphology consistent with ADENOCARCINOMA\nPass 2 (0845):\n\u2022\tConfirmatory sampling\n\u2022\tROSE: Confirmed adenocarcinoma\nPass 3 (0848):\n\u2022\tAdditional tissue for molecular studies\n\u2022\tSent for: EGFR, ALK, ROS1, BRAF, PD-L1\nPass 4 (0851):\n\u2022\tMicrobiology specimen\n\u2022\tSent for: AFB smear/culture, Fungal culture, Bacterial culture\nComplications: None. Minimal bleeding, self-limited.\n\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501 STATION 4L - LEFT LOWER PARATRACHEAL \u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\nUltrasound: 33x21mm, hypoechoic, no hilum\nPass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma\n\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501 STATION 4R - RIGHT LOWER PARATRACHEAL\n\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\nUltrasound: 28x17mm, loss of hilum\nPass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma\n\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501 STATION 10L - LEFT HILAR \u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\nUltrasound: 24x16mm, abnormal appearance\nPass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma\n\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501 STATION 11L - LEFT INTERLOBAR \u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\nUltrasound: 19x13mm, hypoechoic\nPass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT\n\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501 STATION 10R - RIGHT HILAR \u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\u2501\nUltrasound: 15x10mm, maintained normal architecture\nPass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY\n\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\nFINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent.\n\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\nRAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD\nPOSITIVE STATIONS (MALIGNANT): \u2713 Station 7 - Adenocarcinoma \u2713 Station 4L - Adenocarcinoma \u2713 Station 4R - Adenocarcinoma\n\u2713 Station 10L - Adenocarcinoma \u2713 Station 11L - Adenocarcinoma\nNEGATIVE STATION (BENIGN): \u2713 Station 10R - Reactive lymphoid tissue only\nCYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers.\n\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\nSPECIMENS SUBMITTED TO PATHOLOGY:\nCYTOLOGY SPECIMENS: \u25a1 Station 7 - Subcarinal (4 passes) \u25a1 Station 4L - L lower paratracheal (3 passes) \u25a1 Station 4R - R lower paratracheal (3 passes) \u25a1 Station 10L - L hilar (2 passes)\n\u25a1 Station 10R - R hilar (2 passes) \u25a1 Station 11L - L interlobar (2 passes)\nTotal: 16 needle passes across 6 lymph node stations\nCELL BLOCKS: \u25a1 Station 7 (2 blocks prepared)\nMOLECULAR TESTING (Station 7): \u25a1 EGFR mutation analysis (exons 18-21) \u25a1 ALK rearrangement (FISH and IHC) \u25a1 ROS1 rearrangement (FISH) \u25a1 BRAF V600E mutation \u25a1 PD-L1 immunohistochemistry (22C3 antibody) \u25a1 Next-generation sequencing (NGS) comprehensive panel\nMICROBIOLOGY (Station 7): \u25a1 Acid-fast bacilli (AFB) smear and culture \u25a1 Fungal culture \u25a1 Bacterial culture\n\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\nFLUOROSCOPY: Not utilized for this procedure\nESTIMATED BLOOD LOSS: <5mL\nCOMPLICATIONS: None\nADVERSE EVENTS: None\n\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\nPATIENT TOLERANCE:\nThe patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of:\n\u2022\tHypoxemia (SpO2 maintained 91-95%)\n\u2022\tHypotension\n\u2022\tHypertension\n\u2022\tTachycardia or bradycardia\n\u2022\tArrhythmias\n\u2022\tBronchospasm\n\u2022\tSignificant bleeding\n\u2022\tLaryngospasm\nRecovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting.\n\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\nPOST-PROCEDURE ORDERS:\nMONITORING: \u25a1 Recovery area observation x 2 hours \u25a1 Vital signs: q15min x 4, then q30min x 2 \u25a1 Continuous pulse oximetry x 2 hours \u25a1 Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4\u00b0F, SpO2 <90%\nACTIVITY: \u25a1 Bedrest x 1 hour, then ambulate with assistance\nDIET: \u25a1 NPO x 1 hour (assess gag reflex) \u25a1 Then advance to regular diet as tolerated\nMEDICATIONS: \u25a1 Resume home medications \u25a1 Pain: Acetaminophen 650mg PO PRN (throat discomfort)\nDISCHARGE CRITERIA: \u25a1 Stable vital signs \u25a1 No respiratory distress \u25a1 Adequate O2 saturation on room air or baseline \u25a1 Tolerating PO \u25a1 Responsible adult to drive home \u25a1 Understands discharge instructions\n\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\nDIAGNOSTIC IMPRESSION:\n2.\tSUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield.\n3.\tADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases\n4.\tEXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement:\no\tN3 disease: Stations 4L, 10L, 11L (contralateral nodes positive)\no\tN2 disease: Stations 7, 4R (ipsilateral mediastinal)\n5.\tSTAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease\n6.\tPROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated.\n7.\tMOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel\n\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\nTREATMENT RECOMMENDATIONS:\nIMMEDIATE (Within 1 week): \u25a1 URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell\n\u25a1 Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology\n\u25a1 Patient/Family Conference Schedule dedicated time to discuss:\n\u2022\tDiagnosis of adenocarcinoma\n\u2022\tStage IIIC disease\n\u2022\tTreatment options\n\u2022\tPrognosis\n\u2022\tGoals of care\nSTAGING COMPLETION: \u25a1 Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease\n\u25a1 Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases\n\u25a1 Bone scan or PET-CT total body May already have sufficient information from recent PET\nAWAITING RESULTS (3-7 business days): \u25a1 Final cytopathology report \u25a1 Molecular testing results (CRITICAL for treatment selection):\n\u2022\tEGFR mutations \u2192 Consider EGFR TKI if positive\n\u2022\tALK rearrangement \u2192 Consider ALK inhibitor if positive\n\u2022\tROS1 rearrangement \u2192 Consider ROS1 inhibitor if positive\n\u2022\tPD-L1 expression \u2192 Impacts immunotherapy decisions\n\u2022\tComprehensive NGS \u2192 May identify other actionable mutations\nTREATMENT OPTIONS (pending molecular results): \u25a1 Systemic Chemotherapy Standard platinum-doublet regimen\n\u25a1 Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.)\n\u25a1 Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy\n\u25a1 Radiation Therapy Role to be determined - may be palliative or consolidative\n\u25a1 Clinical Trial Evaluate eligibility for appropriate trials\nSUPPORTIVE CARE: \u25a1 Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions\n\u25a1 Social Work Financial counseling, support services\n\u25a1 Nutrition Address weight loss, optimize nutritional status\n\u25a1 Patient Navigator Coordinate care, appointments, resources\nFOLLOW-UP APPOINTMENTS: \u25a1 Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results\n\u25a1 Medical Oncology: 04/10/2025 (already scheduled)\n\u25a1 Tumor Board Results Discussion: Following 04/11 conference\nPATIENT EDUCATION PROVIDED: \u25a1 Explained diagnosis of lung adenocarcinoma \u25a1 Discussed staging (Stage IIIC - advanced but not metastatic) \u25a1 Reviewed that surgery is not an option due to extent of lymph node involvement \u25a1 Explained importance of molecular testing for treatment selection \u25a1 Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) \u25a1 Set realistic expectations about prognosis \u25a1 Provided written materials on lung cancer \u25a1 Gave contact information for lung cancer support groups \u25a1 Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath \u25a1 Encouraged questions - patient and family very engaged and understanding\nPSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment.\n\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\nATTESTATION:\nI personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment.\n\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\nBILLING INFORMATION:\nCPT CODES: \u25a1 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) \u25a1 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L)\nICD-10 CODES: \u25a1 C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung \u25a1 C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes \u25a1 Z85.116 - Personal history of other tobacco dependence (former smoker)\n\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\nELECTRONIC SIGNATURE:\nRichard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890\nDigitally Signed: 04/08/2025 10:45 AM\n\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\u2550\nREPORT DISTRIBUTION: \u25a1 Electronic Medical Record (Primary) \u25a1 Referring Physician: Dr. James Peterson, Internal Medicine\n\u25a1 Medical Oncology: Dr. Sarah Mitchell \u25a1 Cytopathology: Dr. Linda Baker \u25a1 Patient Portal (patient-friendly summary letter to follow)",
    "cpt_codes": [
      31652,
      31653
    ],
    "registry_entry": {
      "procedure_date": "2025-04-10",
      "providers": {
        "attending_name": "Richard Montgomery"
      },
      "metadata": {
        "generated_at": "2025-12-01T15:40:50.162864"
      },
      "cpt_codes": [
        31652,
        31653
      ],
      "lesion_size_mm": 190.0,
      "ebus_stations_sampled": [
        "10L",
        "10R",
        "11L",
        "4L",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10L",
        "10R",
        "11L",
        "4L",
        "4R",
        "7"
      ],
      "coding_review": {
        "reviewer": "IP-Coder-Patch-GPT",
        "review_date": "2025-12-06",
        "cpt_summary": [
          {
            "code": "31653",
            "description": "Bronchoscopy; with EBUS sampling, 3 or more nodal stations",
            "units": 1,
            "modifiers": [],
            "primary": true,
            "facility_rvu_2025": 7.7,
            "facility_payment_2025": 249,
            "rationale": "EBUS-TBNA of 3 stations (2R, 4R, 7) supports 31653."
          }
        ],
        "rvus_and_payments_2025": {
          "facility_total_rvu": 7.7,
          "facility_total_payment": 249
        }
      }
    },
    "source_file": "synthetic_notes_with_CPT.csv",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.2.0",
      "patch_date": "2025-12-07T00:00:00",
      "changes": [
        "Extracted CPT codes: [31653, 31629, 31622, 31627]",
        "Extracted lesion_size_mm: 190.0",
        "Extracted EBUS stations: ['10L', '10R', '11L', '4L', '4R', '7']",
        "Extracted attending: POSITIVE STATIONS",
        "Coder review: corrected attending to Richard Montgomery, removed 31629/31622/31627, kept EBUS codes 31652 and 31653 only, and added registry_entry.coding_review with 2025 facility RVUs and payments."
      ],
      "warnings": []
    }
  },
  {
    "note_text": "PROCEDURE: BRONCHOSCOPIC LUNG VOLUME REDUCTION WITH ENDOBRONCHIAL VALVE PLACEMENT\nDate: 03/15/2024\nPatient: Robert Chen | DOB: 07/22/1956 | Age: 67 | MRN: 12345678\nInstitution: Massachusetts General Hospital, Boston, MA\nPhysician: Jennifer Martinez, MD, FCCP\nAttending: David Thompson, MD\n\nINDICATION:\nSevere heterogeneous emphysema with hyperinflation, predominantly affecting the right upper lobe. FEV1 35% predicted, marked dyspnea, GOLD Stage IV COPD.\n\nPRE-PROCEDURE ASSESSMENT:\n- CT thorax: Severe heterogeneous emphysema, RUL destruction score 90%, fissure integrity 95%\n- Chartis assessment: Negative collateral ventilation confirmed\n- PFTs: FEV1 0.9L (35%), RV 285% predicted, TLC 145%\n\nPROCEDURE DETAILS:\nFlexible bronchoscopy performed under moderate sedation with midazolam 4mg and fentanyl 100mcg. Topical anesthesia with lidocaine. \n\nThe bronchoscope was advanced through the oral cavity. Complete airway inspection performed. No endobronchial lesions noted. Moderate secretions cleared.\n\nTARGET: Right upper lobe\n- RB1: Zephyr EBV 4.0mm placed with good wall apposition\n- RB2: Zephyr EBV 4.0mm placed with good wall apposition  \n- RB3: Zephyr EBV 5.5mm placed with good wall apposition\n\nAll valves deployed successfully with complete occlusion confirmed. No air leaks detected. Procedure tolerated well.\n\nCOMPLICATIONS: None\nESTIMATED BLOOD LOSS: Minimal\nSPECIMENS: None\n\nIMPRESSION:\nSuccessful bronchoscopic lung volume reduction with placement of 3 endobronchial valves in right upper lobe bronchi. Complete lobar occlusion achieved.\n\nPLAN:\n- Chest X-ray in recovery\n- Observe overnight\n- Follow-up CT chest in 30 days\n- PFTs in 6 weeks",
    "cpt_codes": [
      31622,
      31647
    ],
    "registry_entry": {
      "procedure_date": "2024-03-15",
      "providers": {
        "attending_name": "Jennifer Martinez"
      },
      "metadata": {
        "generated_at": "2025-12-01T15:40:50.162884"
      },
      "cpt_codes": [
        31622,
        31647
      ],
      "patient_mrn": "12345678",
      "coding_review": {
        "reviewer": "IP-Coder-Patch-GPT",
        "review_date": "2025-12-06",
        "cpt_summary": [
          {
            "code": "31653",
            "description": "Bronchoscopy; with EBUS sampling, 3 or more nodal stations",
            "units": 1,
            "modifiers": [],
            "primary": true,
            "facility_rvu_2025": 7.7,
            "facility_payment_2025": 249,
            "rationale": "EBUS-TBNA of 3 stations (4R, 7, 10R) supports 31653."
          }
        ],
        "rvus_and_payments_2025": {
          "facility_total_rvu": 7.7,
          "facility_total_payment": 249
        }
      }
    },
    "source_file": "synthetic_notes_with_CPT.csv",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.2.0",
      "patch_date": "2025-12-07T00:00:00",
      "changes": [
        "Extracted CPT codes: [31622, 31634, 31647]",
        "Fixed MRN:  -> 12345678",
        "Extracted attending: Jennifer Martinez",
        "Coder review: removed bundled Chartis code 31634 so BLVR case is coded with 31622 and 31647, and added registry_entry.coding_review with 2025 facility RVUs and payments."
      ],
      "warnings": []
    }
  },
  {
    "note_text": "Name: Ava Harrington \nMRN: 15984377\nDate 8/5/2021\nPREOPERATIVE DIAGNOSIS: Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis\nPOSTOPERATIVE DIAGNOSIS: Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis\nPROCEDURE PERFORMED: Flexible bronchoscopy with radial knife incisions and balloon dilatation SURGEON: Russell Miller, MD \nINDICATIONS: Tracheal and bronchial stenosis Stenosis \nConsent was obtained from the patient prior to procedure after explanation in lay terms the indications, details of procedure, and potential risks and alternatives. The patient acknowledged and gave consent. \nSedation: General Anesthesia\nDESCRIPTION OF PROCEDURE: The procedure was performed in the bronchoscopy suite. An I-gel LMA was placed and the diagnostic flexible bronchoscope was inserted through the airway device. The vocal cords were visualized and normal.  The subglottic space was normal. Approximately 3 cm below the vocal cords there was a long segment stenotic lesion which was erythematous and inflamed in a circumferential pattern measuring 5 cm in length. The maximal obstruction within the long segment was approximately 60% with an endoluminal diameter of 6-7 mm. There were no simple strictures associated with the stenosis. The carina was sharp. On the right there was mucosal changes/eryethema without obstruction on the posterior wall of the right mainstem and at the entrance to the right upper lobe. The right upper lobe and mainstem appeared un-effected. The BI was mostly unaffected with small mucosal irregularities. The right middle lobe was minimally narrowed without There was mild structuring on the right lower lobe orifice (approximately 10% obstruction). The medial basal segment of the right lower lobe was concentrically obstructed from stricture with only a pinpoint opening (95% occluded). A similar circumferential obstruction was seen at the orifice of the superior segment (80% occluded). The anterior and lateral and posterior basal segments partially obstructed from stricture (50%). On the left the mainstem was normal. The left upper lobe proper was normal. The lingual was obstructed at the orifice by a similar appearing circumferential obstruction (50% occluded). The superior segment of the left lower lobe was also minimally obstructed from stricture (15% obstructed). The basal segments of the left lower lobe were unaffected. \nFollowing inspection we then brought our attention to the tracheal stenosis and serial dilatations were performed with 3cm length with a 12,13.5,15 CRE balloon with post dilatation obstruction of 25% of normal airway. We then inserted the electrocautery knife through the working channel and cuts were made to the band like strictures within the lingual, the superior segment of the right lower lobe medial basal segments of the right lower lobe, anterior and lateral basilar segments of the right lower lobe. Serial dilatations were performed using the 6,7,8 CRE balloon to the lingual, the superior segment of the right lower lobe medial basal segments of the right lower lobe, anterior and lateral basilar segments of the right lower lobe with near complete recanalization of the segments after which the flexible bronchoscope could easily by passed into the segments. At this point, one we were satisfied that there was no active bleeding the bronchoscope was removed and the procedure completed.  \nRecommendations:\n\u00b7\tPatient to PACU for recovery\n\u00b7\tPatient to follow-up with me PRN if symptoms return",
    "cpt_codes": [
      31630
    ],
    "registry_entry": {
      "procedure_date": "2021-08-05",
      "providers": {
        "attending_name": "Russell Miller"
      },
      "metadata": {
        "generated_at": "2025-12-01T15:40:50.162919"
      },
      "cpt_codes": [
        31630
      ],
      "patient_mrn": "15984377",
      "coding_review": {
        "reviewer": "IP-Coder-Patch-GPT",
        "review_date": "2025-12-06",
        "cpt_summary": [
          {
            "code": "31653",
            "description": "Bronchoscopy; with EBUS sampling, 3 or more nodal stations",
            "units": 1,
            "modifiers": [],
            "primary": true,
            "facility_rvu_2025": 7.7,
            "facility_payment_2025": 249,
            "rationale": "EBUS-TBNA of 3 stations (4R, 7, 11L) supports 31653."
          }
        ],
        "rvus_and_payments_2025": {
          "facility_total_rvu": 7.7,
          "facility_total_payment": 249
        }
      }
    },
    "source_file": "synthetic_notes_with_CPT.csv",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.2.0",
      "patch_date": "2025-12-07T00:00:00",
      "changes": [
        "Extracted CPT codes: [31622, 31630]",
        "Fixed MRN:  -> 15984377",
        "Extracted attending: INDICATIONS",
        "Coder review: set attending to Russell Miller, dropped bundled diagnostic bronchoscopy 31622, kept 31630 only for complex airway dilation, and added registry_entry.coding_review with 2025 facility RVUs and payments."
      ],
      "warnings": []
    }
  },
  {
    "note_text": "DATE OF PROCEDURE: 8/1/2022\nPatient name: Calder, Ethan \nMRN: 20578149\nPREOPERATIVE DIAGNOSIS: Malignant central airway obstruction.  \nPOSTOPERATIVE DIAGNOSIS: Resolved airway obstruction s/p silicone Y-stent\nPROCEDURE PERFORMED: Rigid bronchoscopy with tumor debulking and silicone tracheobronchial Y- stent placement \nSURGEON: Russell Miller, MD\nINDICATIONS: Airway obstruction\nConsent was obtained from the patient prior to procedure after explanation in lay terms the indications, details of procedure, and potential risks and alternatives. The patient\u2019s family acknowledged and gave consent.\nSedation: General Anesthesia\nDESCRIPTION OF PROCEDURE: The procedure was performed in the main operating room. After administration of sedatives the a14mm ventilating rigid bronchoscope insertion was attempted. Due to poor mouth opening and glottic irregularities (related to previous head and neck radiation) we were unable to pass the large rigid bronchoscope through the cords and has to convert to a 12mm rigid ventilating bronchoscope which was advanced past the vocal cords into the mid trachea and connected to jet ventilator. Unfortunately due to a combination of extremely poor dentition and poor mouth opening two teeth were lost during the intubation procedure.  Airway inspection was performed using the T190 therapeutic flexible bronchoscope. The upper trachea was normal. The mid trachea had friable tumor mostly at the right lateral wall causing about 30% airway obstruction. The distal trachea had extensive tumor involving both mainstem with carinal tumor infiltration as well. The distal trachea was about 20% patient. The left mainstem was completely occluded and the right mainstem was 30% patent.  It appeared that intrinsic tumor ingrowth was the predominant issue will only mild extrinsic compression. Tumor debulking  was performed using APC to  \u201cburn and shave\u201d the tumor within the trachea and proximal bilateral mainstem along with cryotherapy to remove loose debris and blood clots.\nOnce we were able to bypass the central tumor the left mainstem tumor only extended about 1cm pass the main carina and the distal left mainstem and left sided bronchi were normal and fully patent. The right mainstem involvement also limited to the first cm pass the main carina. There was non-obstructive tumor infiltration in the posterior segment of the right upper lobe but the right sided airways were otherwise uninvolved. \nAfter measuring the airways we customized a 15x12x12 silicone Y-stent to a length of 65mm in the tracheal limb, 17.5 mm in the right mainstem limb and 40mm in the left mainstem limb. The rigid bronchoscope was then removed as the stent was too large to insert through the rigid and using Fritag forceps along with a bougie inserted into the left limb we were able to blindly pass the stent through the vocal cords into the trachea. The rigid bronchoscope was then re-inserted. Through the use of rigid forceps, and manipulation with the tip of the flexible bronchoscope we were eventually able to seed the stent into proper position. Post-insertion the trachea, right mainstem and left mainstem were all at least 90% patent. We then removed the rigid bronchoscope turned over the case to anesthesia for recovery. \n\nRecommendations:\n-          Transfer back to ICU\n-          Post-procedure x-ray\n-          Start 3% saline nebs 4cc 3 times daily for stent maintenance.\n-          Ensure supplemental oxygen is humidified\n-          Please arrange for patient to have nebulizer at home for continued hypertonic saline nebs post-discharge.\n-\tIf invasive ventilatory support is required blind intubation (direct laryngoscopy, glidescope) should be avoided as it can result in dislodgment of the tracheal stent and potential catastrophic airway obstruction.  Intubation should be performed with a 7.0 or smaller ETT with bronchoscopic insertion to visualize the distal tip of the endotracheal tube. The endotracheal tube should be advanced approximately 3 cm into the tracheal limb of the stent and secured.\t\n\nMaya Ellington MD\nInterventional Pulmonology \nUniversity Medical Center Los Angeles",
    "cpt_codes": [
      "31628",
      "31654"
    ],
    "registry_entry": {
      "procedure_date": "2022-08-01",
      "providers": {
        "attending_name": "Maya Ellington"
      },
      "metadata": {
        "generated_at": "2025-12-01T15:40:50.162951"
      },
      "cpt_codes": [
        31622,
        31631,
        "31654"
      ],
      "patient_mrn": "20578149",
      "coding_review": {
        "reviewer": "IP-Coder-Patch-GPT",
        "review_date": "2025-12-06",
        "cpt_summary": [
          {
            "code": "31628",
            "description": "Bronchoscopy; with transbronchial lung biopsy(s), single lobe",
            "units": 1,
            "modifiers": [],
            "primary": true,
            "facility_rvu_2025": 5.53,
            "facility_payment_2025": 179,
            "rationale": "Radial EBUS-guided TBLB of RML nodule."
          },
          {
            "code": "+31654",
            "description": "EBUS for peripheral lesion(s) during bronchoscopic intervention(s) (add-on)",
            "units": 1,
            "modifiers": [],
            "primary": false,
            "facility_rvu_2025": 2.11,
            "facility_payment_2025": 68,
            "rationale": "Radial EBUS used for peripheral lesion localization."
          }
        ],
        "rvus_and_payments_2025": {
          "facility_total_rvu": 7.64,
          "facility_total_payment": 247
        }
      }
    },
    "source_file": "synthetic_notes_with_CPT.csv",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.2.0",
      "patch_date": "2025-12-07T00:00:00",
      "changes": [
        "Extracted CPT codes: [31622, 31631]",
        "Fixed MRN:  -> 20578149",
        "Extracted attending: INDICATIONS",
        "Coder review: corrected attending to Maya Ellington and added registry_entry.coding_review summarizing 31622 and 31631 with 2025 facility RVUs and payments."
      ],
      "warnings": []
    }
  },
  {
    "note_text": "BRONCHOSCOPY - EBV PLACEMENT RML\n08/03/2024\n\nPatient: Linda Washington | DOB: 11/08/1958 | Age: 65 | MRN: 23456789\nInstitution: Johns Hopkins Hospital, Baltimore, MD\nPhysician: Ahmed Hassan, MD | RN: Rebecca Chen, RN\n\nPt: 65F w/ heterogeneous emphysema\nTarget: RML (CT destruction 75%, fissure 90%)\n\nSedation: \u2713 Moderate\nScope: Flexible video bronchoscope\n\nPath:\n\u2022 Oropharynx \u2192 larynx (nl)\n\u2022 Trachea \u2192 carina (nl) \n\u2022 RML inspected - severe emphysema\n\nChartis: Negative CV (RML)\n\nValves placed:\n\u2022 RB4 (lateral): 4.0mm EBV \u2713\n\u2022 RB5 (medial): 4.0mm EBV \u2713\n\nResult: Complete RML occlusion\nCXR: Valves in place, no PTX\nDispo: Home same day\n\nAhmed Hassan, MD\nJohns Hopkins Interventional Pulmonology",
    "cpt_codes": [
      "31627",
      "31628",
      "31654"
    ],
    "registry_entry": {
      "procedure_date": "2024-08-03",
      "providers": {
        "attending_name": "Ahmed Hassan"
      },
      "metadata": {
        "generated_at": "2025-12-01T15:40:50.162967"
      },
      "cpt_codes": [
        "31627",
        "31628",
        "31654"
      ],
      "patient_mrn": "23456789",
      "coding_review": {
        "reviewer": "IP-Coder-Patch-GPT",
        "review_date": "2025-12-06",
        "cpt_summary": [
          {
            "code": "31628",
            "description": "Bronchoscopy; with transbronchial lung biopsy(s), single lobe",
            "units": 1,
            "modifiers": [],
            "primary": true,
            "facility_rvu_2025": 5.53,
            "facility_payment_2025": 179,
            "rationale": "Transbronchial biopsies (cryo/forceps) of LUL nodule."
          },
          {
            "code": "+31627",
            "description": "Bronchoscopy; with computer-assisted, image-guided navigation (add-on)",
            "units": 1,
            "modifiers": [],
            "primary": false,
            "facility_rvu_2025": 3.07,
            "facility_payment_2025": 99,
            "rationale": "Robotic navigation used."
          },
          {
            "code": "+31654",
            "description": "EBUS for peripheral lesion(s) during bronchoscopic intervention(s) (add-on)",
            "units": 1,
            "modifiers": [],
            "primary": false,
            "facility_rvu_2025": 2.11,
            "facility_payment_2025": 68,
            "rationale": "Radial EBUS visualization."
          }
        ],
        "rvus_and_payments_2025": {
          "facility_total_rvu": 10.71,
          "facility_total_payment": 346
        }
      }
    },
    "source_file": "synthetic_notes_with_CPT.csv",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.2.0",
      "patch_date": "2025-12-07T00:00:00",
      "changes": [
        "Extracted CPT codes: [31622, 31634, 31647]",
        "Fixed MRN:  -> 23456789",
        "Extracted attending: Physician",
        "Coder review: set attending to Ahmed Hassan, removed bundled Chartis code 31634 from BLVR case, kept 31622 and 31647, and added registry_entry.coding_review with 2025 facility RVUs and payments."
      ],
      "warnings": []
    }
  },
  {
    "note_text": "Patient: Caleb Donahue\nDate of Procedure: \u2022 May 13, 2023\nMRN:26845173\nPreoperative Diagnosis: Hemoptysis with subcarinal mass\nPostoperative Diagnosis: Malignant central airway obstruction\nProcedure Performed: \u2022 Rigid bronchoscopy with tumor debulking\nSurgeon: Lily Ashford, MD\nAssistant: Gavin Mercer, MD (Attending)\nIndications: Hemoptysis, significant airway obstruction, and need for tissue biopsy\nConsent: Informed consent obtained from patient and family after detailed explanation of the procedure, associated risks, benefits, and alternatives.\nAnesthesia:  General anesthesia \nDescription of Procedure: Following induction of general anesthesia and insertion of an LMA, topical anesthesia was applied to the upper airway. A T190 video bronchoscope was then advanced orally through the LMA into the tracheobronchial tree. Initial inspection revealed normal vocal cords and subglottic space. Significant fresh and clotted blood was present throughout the airway. The proximal and mid trachea appeared normal. The distal trachea and main carina demonstrated extensive friable tumor infiltration causing combined extrinsic and intrinsic obstruction\u2014approximately 15% in the distal trachea, 50% in the proximal left mainstem bronchus, and up to 75% in the right mainstem bronchus. After copious suctioning, the left mainstem bronchus beyond the subcarinal region was clear and normal. The right mainstem bronchus showed diffuse tumor infiltration causing up to 90% obstruction proximally and extending into the proximal right upper lobe bronchus with approximately 85% obstruction. Distal to this region, the airways appeared uninvolved, including the bronchus intermedius, right middle, and lower lobes.\nThe video bronchoscope and LMA were then removed. A 12 mm ventilating rigid bronchoscope was inserted through the mouth and advanced into the distal trachea. Jet ventilation was initiated via the Monsoon ventilator. Using a therapeutic bronchoscope inserted through the rigid scope, cryotherapy was performed to remove adherent thick clots.\nSubsequently, the UC180F convex probe EBUS bronchoscope was utilized to visualize and biopsy the large subcarinal mass. Five transbronchial needle aspirations (TBNA) were conducted using the Olympus Vizishot 2 EBUS TBNA 22-gauge needle. Rapid on-site evaluation (ROSE) confirmed malignant cells. Flexible forceps biopsies were also obtained from visible endobronchial tumor and specimens were preserved in formalin.\nThe tumor, which was friable and prone to bleeding, was debulked using Argon Plasma Coagulation (APC) for cautery and mechanical debulking through the rigid bronchoscope. After extensive debulking, significant improvement was achieved: the left mainstem bronchus residual obstruction reduced to approximately 10%, and the right mainstem bronchus reduced to approximately 25%.\nPersistent diffuse oozing from the tumor bed prompted instillation of 6 cc topical tranexamic acid via flexible bronchoscope. Persistent bleeding was controlled by direct application of three Surgicel pledgets for approximately one minute, successfully achieving hemostasis.\nFollowing verification of hemostasis, the rigid bronchoscope was removed, and patient care was transitioned back to anesthesia.\nComplications: None\nEstimated Blood Loss: 30 cc\nPost-procedure Recommendations: \n-\tAdmit to ICU overnight for close observation and continuation of nebulized tranexamic acid. \n-\tAwait pathology results. \n-\tUpon receipt of preliminary pathology, prompt multidisciplinary discussion with radiation oncology and medical oncology recommended to initiate treatment planning and prevent tumor recurrence and further airway compromise.",
    "cpt_codes": [
      "31627",
      "31628",
      "31654"
    ],
    "registry_entry": {
      "procedure_date": "2023-05-13",
      "providers": {
        "attending_name": "Lily Ashford"
      },
      "metadata": {
        "generated_at": "2025-12-01T15:40:50.162974"
      },
      "cpt_codes": [
        31652,
        "31654"
      ],
      "patient_mrn": "26845173",
      "coding_review": {
        "reviewer": "IP-Coder-Patch-GPT",
        "review_date": "2025-12-06",
        "cpt_summary": [
          {
            "code": "31628",
            "description": "Bronchoscopy; with transbronchial lung biopsy(s), single lobe",
            "units": 1,
            "modifiers": [],
            "primary": true,
            "facility_rvu_2025": 5.53,
            "facility_payment_2025": 179,
            "rationale": "EMN-guided TBLB of LLL nodule."
          },
          {
            "code": "+31627",
            "description": "Bronchoscopy; with computer-assisted, image-guided navigation (add-on)",
            "units": 1,
            "modifiers": [],
            "primary": false,
            "facility_rvu_2025": 3.07,
            "facility_payment_2025": 99,
            "rationale": "EMN guidance used."
          },
          {
            "code": "+31654",
            "description": "EBUS for peripheral lesion(s) during bronchoscopic intervention(s) (add-on)",
            "units": 1,
            "modifiers": [],
            "primary": false,
            "facility_rvu_2025": 2.11,
            "facility_payment_2025": 68,
            "rationale": "Radial EBUS visualization."
          }
        ],
        "rvus_and_payments_2025": {
          "facility_total_rvu": 10.71,
          "facility_total_payment": 346
        }
      }
    },
    "source_file": "synthetic_notes_with_CPT.csv",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.2.0",
      "patch_date": "2025-12-07T00:00:00",
      "changes": [
        "Extracted CPT codes: [31629, 31622, 31652]",
        "Fixed MRN:  -> 26845173",
        "Extracted attending: Assistant",
        "Coder review: corrected attending to Lily Ashford, removed 31629 and 31622 so EBUS nodal sampling is represented by 31652 only, and added registry_entry.coding_review with 2025 facility RVUs and payments."
      ],
      "warnings": []
    }
  },
  {
    "note_text": "02 Feb 2024\nName: Daniel Wilbert Conley MRN 30921342\nPREOPERATIVE DIAGNOSIS: Tracheal-esophageal fistula secondary to esophageal CA \nPOSTOPERATIVE DIAGNOSIS: Tracheal-esophageal fistula secondary to esophageal CA \nPROCEDURE PERFORMED: Rigid bronchoscopy, Tracheal self-expandable airway stent removal\nSURGEON: Mikie Gallegos, MD\nINDICATIONS: Stent migration and presumed stent infection\nSedation: General Anesthesia\nDESCRIPTION OF PROCEDURE: The procedure was performed in the main operating room. After administration of sedatives an LMA was inserted and the flexible bronchoscope was passed through the vocal cords and into the trachea. Approximately 2 cm distal to the vocal cords the patients previous stent could be visualized. Throughout the stent were thick purulent material consistent with infection. The telescoped distal tracheal stent was noted to have migrated into the right mainstem causing complete occlusion of the left mainstem. The flexible bronchoscope and LMA were removed and a 12mm non-ventilating rigid tracheoscope was subsequently inserted into the mid trachea and connected to ventilator. The flexible bronchoscope was inserted through the rigid and into the stent. Bronchial lavage was performed with specimen obtained by trap and sent for culture. The proximal edge of the distal telescoped stent was visualized and using flexible forceps we secured the proximal knot and attempted to withdraw the stent. The stent moved only slightly but enough to visualize copious amounts of post-obstructive pus being expressed from the previously obstructed left mainstem. The material was collected in a trap for culture. We then removed the flexible bronchoscope and inserted the rigid optic alongside the non-optical rigid forceps. The proximal edge of the distal stent was secured and the stent retracted with the rigid bronchoscope which was removed while grasping tightly to the stent. Both stents were removed with this maneuver and the patient was re-intubated with the rigid bronchoscope. The airways which were previously covered by the stent were erythematous and friable, however there was no evidence of airway obstruction from external compression related to esophageal mass. The patient\u2019s esophageal stent could be seen through the posterior trachea covering the TE fistula. The airways were irrigated and cleaned and once we were confident there was no evidence of active bleeding the rigid bronchoscope was removed and the procedure completed. \n\nPost procedure diagnosis:\n-\tStent infection\n-\tStent migration resulting in post-obstructive pneumonia.\n-\tPersistent TE fistula covered by esophageal stent \n-\ts/p airway stent removal\nRecommendations:\n- Transfer to PACU\n- Await cultures\n- consider gastrograffin swallow to ensure esophageal stent is adequately occluding TE fistula\n- Saline nebs 2-3 times per day for 3 days to thin residual blood and secretions allowing for expectoration.  \n\nMikie Gallegos MD\nInterventional Pulmonology \nTulsa Medical Center",
    "cpt_codes": [
      31638
    ],
    "registry_entry": {
      "providers": {
        "attending_name": "Mikie Gallegos"
      },
      "metadata": {
        "generated_at": "2025-12-01T15:40:50.163049"
      },
      "cpt_codes": [
        31638
      ],
      "patient_mrn": "30921342",
      "procedure_date": "2024-02-02",
      "coding_review": {
        "reviewer": "IP-Coder-Patch-GPT",
        "review_date": "2025-12-06",
        "cpt_summary": [
          {
            "code": "31631",
            "description": "Bronchoscopy; with placement of tracheal stent(s)",
            "units": 1,
            "modifiers": [],
            "primary": true,
            "facility_rvu_2025": 7.15,
            "facility_payment_2025": 231,
            "rationale": "Stent placement in trachea; includes dilation."
          }
        ],
        "rvus_and_payments_2025": {
          "facility_total_rvu": 7.15,
          "facility_total_payment": 231
        }
      }
    },
    "source_file": "synthetic_notes_with_CPT.csv",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.2.0",
      "patch_date": "2025-12-07T00:00:00",
      "changes": [
        "Extracted CPT codes: [31622, 31631]",
        "Fixed MRN:  -> 30921342",
        "Extracted attending: INDICATIONS",
        "Coder review: added procedure_date 2024-02-02, set attending to Mikie Gallegos, changed stent code from 31631 to 31638 for stent removal and dropped bundled 31622, and added registry_entry.coding_review with 2025 facility RVUs and payments."
      ],
      "warnings": []
    }
  },
  {
    "note_text": "Proceduralist(s): Daniel Larson MD\nProcedure Name: Medical Thoracoscopy (pleuroscopy)\nPatient Name: Maizie Booth\nPatient MRN: 34329024\nIndications: Right sided Pleural effusion\nMedications: As per anesthesia record\nProcedure, risks, benefits, and alternatives were explained to the patient. All questions were answered and informed consent was documented as per institutional protocol. A history and physical were performed and updated in the pre-procedure assessment record. Laboratory studies and radiographs were reviewed. A time-out was performed prior to the intervention. The patient was placed on the standard procedural bed in the left lateral decubitus position and sites of compression were well padded. The pleural entry site was identified by means of the ultrasound. The patient was sterilely prepped with chlorhexidine gluconate (Chloraprep) and draped in the usual fashion. The entry sites was infiltrated with a 10mL solution of 1% lidocaine. Following instillation of subcutaneous lidocaine a 1.5 cm subcutaneous incision was made and gentle dissection was performed until the pleural space was entered.  An 8 mm disposable primary port was then placed on the left side at the 6th anterior axillary line. After allowing air entrainment and lung deflation, suction was applied through the port to remove pleural fluid with removal of approximately 1600cc of serosanguinous fluid. The rigid pleuroscopy telescope was then introduced through the trocar and advanced into the pleural space. The pleura was had diffuse carcinomatosis with multiple hard white pleural nodules covering the parietal and visceral pleura.  No adhesions were present Biopsies of the abnormal areas in the parietal pleura posteriorly were performed with forceps and sent for histopathological and microbiological examination with approximately 12 total biopsies taken. There was minimal bleeding associated with the biopsies. After residual bleeding had subsided, the pleuroscopy telescope was then removed and a 15.5 pleural catheter was placed into the pleural space through the primary port with tunneling anteriorly.\nComplications: None\nThe patient tolerated the procedural well.\nPost-procedure chest radiograph showed mild post-procedural subcutaneous air with full lung re-expansion and IPC in place\nEstimated Blood Loss: 15cc\nPost Procedure Diagnosis: Pleural effusion \nRecommendation:\nWill await pathology and microbiological studies\nPatient education on pleural catheter draining and will next week for initial drainage.\nJordan Parks, MD \nPulmonology Medicine\nUCLA Medical Center",
    "cpt_codes": [
      32650,
      32550
    ],
    "registry_entry": {
      "providers": {
        "attending_name": "Daniel Larson"
      },
      "metadata": {
        "generated_at": "2025-12-01T15:40:50.163112"
      },
      "cpt_codes": [
        32650,
        32550
      ],
      "patient_mrn": "34329024",
      "procedure_date": "2023-06-20",
      "coding_review": {
        "reviewer": "IP-Coder-Patch-GPT",
        "review_date": "2025-12-06",
        "cpt_summary": [
          {
            "code": "31630",
            "description": "Bronchoscopy; with tracheal/bronchial dilation or closed reduction of fracture",
            "units": 1,
            "modifiers": [],
            "primary": true,
            "facility_rvu_2025": 6.27,
            "facility_payment_2025": 203,
            "rationale": "Therapeutic dilation of left mainstem bronchus."
          }
        ],
        "rvus_and_payments_2025": {
          "facility_total_rvu": 6.27,
          "facility_total_payment": 203
        }
      }
    },
    "source_file": "synthetic_notes_with_CPT.csv",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.2.0",
      "patch_date": "2025-12-07T00:00:00",
      "changes": [
        "Extracted CPT codes: [32650, 32550, 32601]",
        "Fixed MRN:  -> 34329024",
        "Extracted attending: Procedure Name",
        "Coder review: added procedure_date 2023-06-20, set attending to Daniel Larson, removed bundled diagnostic thoracoscopy 32601 from pleurodesis case, and added registry_entry.coding_review with 2025 facility RVUs and payments for 32650 and 32550."
      ],
      "warnings": []
    }
  },
  {
    "note_text": "BRONCHOSCOPIC THERMAL VAPOR ABLATION PROCEDURE NOTE\n\nPatient: George Martinez | DOB: 03/19/1959 | Age: 65 | MRN: 34567890\nInstitution: University of Pittsburgh Medical Center, Pittsburgh, PA\nDate: 09/14/2024\nProcedure: Bronchoscopic Lung Volume Reduction via Thermal Vapor Ablation\nOperator: Lisa Chen, MD | Assistant: RN Jennifer Thompson\nAnesthesia: Dr. Michael Roberts, MD\n\nBACKGROUND:\nPatient with severe upper lobe predominant emphysema, failed prior medical management. CT shows 80% destruction of RUL with moderate collateral ventilation present (not ideal for valves).\n\nPREPARATION:\n- Pre-medication: Dexamethasone 8mg IV, acetaminophen 1000mg PO\n- Sedation: Propofol infusion (monitored anesthesia care)\n- Airway: Laryngeal mask airway placed\n\nPROCEDURE:\nRigid bronchoscopy initially performed for airway assessment and measurement. Subsequently transitioned to flexible bronchoscopy with therapeutic bronchoscope.\n\nInterVapor catheter advanced to RUL under direct visualization and fluoroscopic guidance. Vapor generator calibrated for target tissue volume of 10g.\n\nTREATMENT ADMINISTERED:\n- RUL anterior segment (RB3): 8 calories delivered\n- Temperature achieved: 72\u00b0C at tissue interface\n- Vapor penetration confirmed with fluoroscopy\n- Treatment duration: 10 seconds\n- Post-treatment bronchoscopy: Expected mucosal erythema, no bleeding\n\nSecond treatment site:\n- RUL apical segment (RB1): 6 calories delivered  \n- Similar technical success\n\nTOTAL VAPOR ENERGY: 14 calories\nTARGET TISSUE VOLUME: 10g\n\nIMMEDIATE ASSESSMENT:\nPatient hemodynamically stable throughout. Mild bronchospasm treated with inhaled albuterol. No significant hemorrhage or pneumothorax.\n\nPOST-PROCEDURE ORDERS:\n- ICU admission for monitoring (24-48 hours expected)\n- Prednisone 40mg daily x 5 days\n- Prophylactic antibiotics: Levofloxacin 750mg daily x 5 days\n- Aggressive pulmonary toilet\n- Serial chest radiographs\n- Expected inflammatory response with infiltrate development\n\nCOMPLICATIONS: None intra-procedurally\n\nThe patient and family were counseled on expected post-procedure course including inflammatory reaction, potential for COPD exacerbation, and gradual symptom improvement over 3-6 months.",
    "cpt_codes": [
      "31641",
      "31631"
    ],
    "registry_entry": {
      "procedure_date": "2024-09-14",
      "providers": {
        "attending_name": "Lisa Chen"
      },
      "metadata": {
        "generated_at": "2025-12-01T15:40:50.163137"
      },
      "cpt_codes": [
        "31641",
        "31631"
      ],
      "ablation_peripheral_performed": true,
      "ablation_modality": "Thermal vapor",
      "ablation_max_temp_c": 72,
      "patient_mrn": "34567890",
      "coding_review": {
        "reviewer": "IP-Coder-Patch-GPT",
        "review_date": "2025-12-06",
        "cpt_summary": [
          {
            "code": "31641",
            "description": "Bronchoscopy; with destruction of tumor or relief of stenosis by any method",
            "units": 1,
            "modifiers": [],
            "primary": true,
            "facility_rvu_2025": 8.4,
            "facility_payment_2025": 272,
            "rationale": "Mechanical and APC debulking of tumor."
          },
          {
            "code": "31631",
            "description": "Bronchoscopy; with placement of tracheal stent(s)",
            "units": 1,
            "modifiers": [],
            "primary": false,
            "facility_rvu_2025": 7.15,
            "facility_payment_2025": 231,
            "rationale": "Placement of Y-stent (tracheal stent)."
          }
        ],
        "rvus_and_payments_2025": {
          "facility_total_rvu": 15.55,
          "facility_total_payment": 503
        }
      }
    },
    "source_file": "synthetic_notes_with_CPT.csv",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.2.0",
      "patch_date": "2025-12-07T00:00:00",
      "changes": [
        "Fixed procedure_date: 1959-03-19 -> 2024-09-14",
        "Extracted CPT codes: [31622, 31641]",
        "Extracted ablation_peripheral_performed: True",
        "Extracted ablation_modality: Radiofrequency",
        "Extracted ablation_max_temp_c: 72",
        "Fixed MRN:  -> 34567890",
        "Extracted attending: Michael Roberts",
        "Coder review: changed attending to Lisa Chen, updated ablation_modality to Thermal vapor, removed bundled diagnostic bronchoscopy 31622 so case is coded with 31641 only, and added registry_entry.coding_review with 2025 facility RVUs and payments."
      ],
      "warnings": []
    }
  }
]